Sanofi Pasteur SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanofi Pasteur SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014193
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanofi Pasteur SA (Sanofi Pasteur), formerly Aventis Pasteur SA, a subsidiary of Sanofi, is a manufacturer and marketer of vaccines against bacterial and viral diseases. The company provides meningococcal vaccines and seasonal influenza vaccines. Its products are used in the treatment of cholera, diphtheria, haemophilus influenzae type b infections, meningococcal infections, pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, hepatitis A, hepatitis B, influenza, measles, mumps, poliomyelitis and rabies. The company operates in Algeria, Argentina, Australia, Austria, Belgium, Bangladesh, Brazil, Bulgaria, Canada, Chile, China, Malaysia, Pakistan, the Philippines, Russia, South Korea, Mexico and Indonesia, among others. Sanofi Pasteur is headquartered in Lyon, France.

Sanofi Pasteur SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Licensing Agreements 24
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Acquisition 28
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA – Key Competitors 30
Sanofi Pasteur SA – Key Employees 31
Sanofi Pasteur SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 35
Corporate Communications 35
Jun 27, 2017: American Academy of Family Physicians Foundation Launches Highlight on VACCINATIONS 4 TEENS to Help Address Teen Under-Vaccination 35
Product News 36
09/26/2016: BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika 36
06/23/2016: New Four-Strain Influenza Vaccine, VaxigripTetra, regulatory dossier from Sanofi Pasteur now approved in Europe 37
02/02/2016: Sanofi Pasteur To Leverage Its Strong Vaccine Legacy In Hunt For Zika Vaccine 38
Clinical Trials 39
Aug 03, 2016: Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys 39
Mar 29, 2016: Sanofi Pasteur uses novel technology for development of a 2nd-gen influenza vaccine 40
Other Significant Developments 41
Sep 22, 2016: Sanofi Pasteur invests 300 million pesos to triple production capacity at its plant in Argentina 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Key Facts 2
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA, Key Competitors 30
Sanofi Pasteur SA, Key Employees 31
Sanofi Pasteur SA, Other Locations 32
Sanofi Pasteur SA, Subsidiaries 32
Sanofi Pasteur SA, Joint Venture 33

★海外企業調査レポート[Sanofi Pasteur SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AviChina Industry & Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Guardian Media Group plc:企業の戦略・SWOT・財務情報
    Guardian Media Group plc - Strategy, SWOT and Corporate Finance Report Summary Guardian Media Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company oper …
  • Ansaldo Thomassen B.V.:企業の戦略的SWOT分析
    Ansaldo Thomassen B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Banner Corp:企業の戦略・SWOT・財務情報
    Banner Corp - Strategy, SWOT and Corporate Finance Report Summary Banner Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Central National Gottesman Inc:企業の戦略・SWOT・財務分析
    Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report Summary Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Prologis, Inc.:戦略・SWOT・企業財務分析
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Riot Blockchain Inc (RIOT)-医療機器分野:企業M&A・提携分析
    Summary Riot Blockchain Inc (Riot Blockchain), formerly known as Bioptix Inc, is an in-vitro diagnostic company focusing on development of blood-based tests in the diagnosis and treatment of acute appendicitis (AA) in children adolescent and young adult patients. Its product portfolio comprises APPY …
  • Mediobanca Private Banking:企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formation Biologics Inc (Formation Biologics), formerly AvidBiologics Inc is a clinical stage pharmaceutical company that develops biologics and antibody-drug conjugates (ADCs) with selective anti-tumor properties for the treatment of cancer and rare diseases. The company’s pipeline product …
  • PORR AG (POS):企業の財務・戦略的SWOT分析
    PORR AG (POS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Jacobs Engineering Group Inc (JEC)-石油・ガス分野:企業M&A・提携分析
    Summary Jacobs Engineering Group Inc. (Jacobs) is a provider of technical professional services. The company offers a diverse range of technical, professional, and construction services to industrial, commercial, and governmental customers across the globe. Its service portfolio includes project; pr …
  • IDOX Plc (IDOX):企業の財務・戦略的SWOT分析
    Summary IDOX Plc (IDOX) is an information technology company that supplies and develops software solutions and information services. The company offers services such as funding, manages services, government and compliance solutions. Its government services include environmental, legal, democratic, e …
  • Enka Power:企業の戦略的SWOT分析
    Enka Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Intraco Ltd (I06):企業の財務・戦略的SWOT分析
    Intraco Ltd (I06) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Regal Hotels International Holdings Ltd.:戦略・SWOT・企業財務分析
    Regal Hotels International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Regal Hotels International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆